Current Report Filing (8-k)
2018年9月12日 - 6:23AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT
REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): September 11, 2018
ENVISION HEALTHCARE CORPORATION
(Exact name of Registrant as Specified in its Charter)
|
|
|
|
|
Delaware
|
|
001-37955
|
|
62-1493316
|
(State or Other Jurisdiction
|
|
(Commission
|
|
(I.R.S. Employer
|
of Incorporation)
|
|
File Number)
|
|
Identification No.)
|
|
|
|
1A Burton Hills Boulevard
|
|
|
Nashville, Tennessee
|
|
37215
|
(Address of Principal Executive Offices)
|
|
(Zip Code)
|
(615)
665-1283
(Registrants Telephone Number, Including Area Code)
Not Applicable
(Former
Name or Former Address, if Changed Since Last Report)
Check the
appropriate box below if the
Form 8-K
filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
|
☐
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
☐
|
Soliciting material pursuant to
Rule 14a-12
under the Exchange Act
(17 CFR
240.14a-12)
|
|
☐
|
Pre-commencement
communications pursuant to
Rule 14d-2(b) under
the Exchange Act (17 CFR
240.14d-2(b))
|
|
☐
|
Pre-commencement
communications pursuant to
Rule 13e-4(c) under
the Exchange Act (17 CFR
240.13e-4(c))
|
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405
of this chapter) or Rule
12b-2
of the Securities Exchange Act of 1934
(§240.12b-2
of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 5.07. Submission of Matters to a Vote of Security Holders.
On September 11, 2018, Envision Healthcare Corporation (the Company or Envision) held its Annual Meeting of Stockholders (the
Annual Meeting). At the Annual Meeting, stockholders of the Company voted on the proposals set forth below. The proposals are described in detail in the definitive proxy statement filed on August 13, 2018 by the Company with the
U.S. Securities and Exchange Commission (the SEC). The final voting results on each of the matters submitted to a vote of the Companys stockholders at the Annual Meeting are set forth below.
As of the close of business on August 10, 2018, the record date for the Annual Meeting, there were 121,391,673 shares of the Companys common stock,
par value $0.01 per share (the Common Stock), outstanding, each of which was entitled to one vote for each proposal at the Annual Meeting. At the Annual Meeting, a total of 98,899,477 shares of Common Stock, representing approximately
81.5% of the outstanding shares of Common Stock entitled to vote, were present in person or by proxy, constituting a quorum to conduct business.
1.
|
A proposal to adopt the Agreement and Plan of Merger (the Merger Agreement), dated as of
June 10, 2018, by and among the Company, Enterprise Parent Holdings Inc. (Parent), and Enterprise Merger Sub Inc., an indirect wholly owned subsidiary of Parent (Merger Sub), pursuant to which Merger Sub will merge with
and into the Company, with the Company surviving the merger as an indirect wholly owned subsidiary of Parent (the Merger). The proposal was approved on the basis of the following voting results:
|
|
|
|
|
|
|
|
FOR
|
|
AGAINST
|
|
ABSTAIN
|
|
BROKER NON-VOTES
|
91,908,758
|
|
69,977
|
|
9,815
|
|
6,910,927
|
2.
|
A proposal to approve, on an advisory
(non-binding)
basis, certain
compensation that may be paid or become payable to the Companys named executive officers in connection with the Merger. The proposal was approved on the basis of the following voting results:
|
|
|
|
|
|
|
|
FOR
|
|
AGAINST
|
|
ABSTAIN
|
|
BROKER NON-VOTES
|
83,196,287
|
|
7,904,850
|
|
887,413
|
|
6,910,927
|
3.
|
A proposal to approve the adjournment of the Annual Meeting, if necessary or appropriate, including to solicit
additional proxies if there are insufficient votes at the time of the Annual Meeting to approve the proposal to adopt the Merger Agreement or in the absence of a quorum. The proposal was approved on the basis of the following voting results:
|
|
|
|
|
|
|
|
FOR
|
|
AGAINST
|
|
ABSTAIN
|
|
BROKER NON-VOTES
|
87,799,844
|
|
4,171,099
|
|
17,607
|
|
6,910,927
|
4.
|
A proposal to elect four members to the Envision board of directors for terms ending at the 2021 annual meeting
of stockholders. The stockholders elected each of the nominees to the Envision board of directors on the basis of the following voting results:
|
|
|
|
|
|
|
|
|
|
|
|
FOR
|
|
AGAINST
|
|
ABSTAIN
|
|
BROKER NON-VOTES
|
John T. Gawaluck
|
|
91,271,950
|
|
527,035
|
|
189,565
|
|
6,910,927
|
Joey A. Jacobs
|
|
83,335,078
|
|
8,465,918
|
|
187,554
|
|
6,910,927
|
Kevin P. Lavender
|
|
75,071,480
|
|
16,729,507
|
|
187,563
|
|
6,910,927
|
Leonard M. Riggs, Jr., M.D.
|
|
91,253,208
|
|
547,887
|
|
187,455
|
|
6,910,927
|
5.
|
A proposal to approve certain amendments to the Companys certificate of incorporation, including the
declassification of the Envision board of directors and the elimination of the Series
A-1
Mandatory Convertible Preferred Stock. The proposal was approved on the basis of the following voting results:
|
|
|
|
|
|
|
|
FOR
|
|
AGAINST
|
|
ABSTAIN
|
|
BROKER NON-VOTES
|
90,825,418
|
|
296,594
|
|
866,538
|
|
6,910,927
|
6.
|
A proposal to approve, on an advisory
(non-binding)
basis, the
compensation of the Companys named executive officers. The proposal was not approved on the basis of the following voting results:
|
|
|
|
|
|
|
|
FOR
|
|
AGAINST
|
|
ABSTAIN
|
|
BROKER NON-VOTES
|
40,741,886
|
|
50,201,169
|
|
1,045,495
|
|
6,910,927
|
7.
|
A proposal to ratify the appointment of Deloitte & Touche LLP as the Companys independent
registered public accounting firm for the current fiscal year. The proposal was approved on the basis of the following voting results:
|
|
|
|
|
|
|
|
FOR
|
|
AGAINST
|
|
ABSTAIN
|
|
BROKER NON-VOTES
|
96,062,726
|
|
2,738,168
|
|
98,583
|
|
|
Item 8.01. Other Items.
The Company now anticipates that the Merger will close during October 2018.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.
|
|
|
Envision Healthcare Corporation
|
|
|
By:
|
|
/s/ Kevin D. Eastridge
|
|
|
Kevin D. Eastridge
Executive Vice President
and
Chief Financial Officer
|
Date: September 11, 2018
ENVISION HEALTHCARE HOLDINGS, IN (NYSE:EVHC)
過去 株価チャート
から 11 2024 まで 12 2024
ENVISION HEALTHCARE HOLDINGS, IN (NYSE:EVHC)
過去 株価チャート
から 12 2023 まで 12 2024
Real-Time news about Envision Healthcare Corp. (delisted) (ニューヨーク証券取引所): 0 recent articles
その他のEnvision Healthcare Corpニュース記事